Prediction of m6A and m5C at single-molecule resolution reveals a cooccurrence of RNA modifications across the transcriptome

P. Acera Mateos,A.J. Sethi,A. Ravindran,A. Srivastava,K. Woodward,S. Mahmud,M. Kanchi,M. Guarnacci,J. Xu,Z.W.S. Yuen,Y. Zhou,A. Sneddon,W. Hamilton,J. Gao,L.M. Starrs,R. Hayashi,V. Wickramasinghe,K. Zarnack,T. Preiss,G. Burgio,N. Dehorter,N. Shirokikh,E. Eyras
DOI: https://doi.org/10.1101/2022.03.14.484124
2024-03-02
Abstract:The epitranscriptome embodies many new and largely unexplored functions of RNA. A significant roadblock hindering progress in epitranscriptomics is the identification of more than one modification in individual transcript molecules. We address this with CHEUI (CH3 (methylation) Estimation Using Ionic current). CHEUI predicts N6-methyladenosine (m6A) and 5-methylcytidine (m5C) in individual molecules from the same sample, the stoichiometry at transcript reference sites, and differential methylation between any two conditions. CHEUI processes observed and expected nanopore direct RNA sequencing signals to achieve high single-molecule, transcript-site, and stoichiometry accuracies in multiple tests using synthetic RNA standards and cell line data. CHEUI’s capability to identify two modification types in the same sample reveals a co-occurrence of m6A and m5C in individual mRNAs in cell line and tissue transcriptomes. CHEUI provides new avenues to discover and study the function of the epitranscriptome.
Bioinformatics
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is the identification and quantification of RNA modifications at the single - molecule level. Specifically, the authors developed a method named CHEUI (CH3 (methylation) Estimation Using Ionic current), aiming to predict the existence of two RNA modifications, N6 - methyladenosine (m6A) and 5 - methylcytosine (m5C), from the same sample, and to be able to determine the positions of these modifications in the transcriptome and the differential methylation under different conditions. CHEUI achieves high - precision single - molecule, transcriptional - site and stoichiometric - ratio detection by processing nanopore direct RNA sequencing (DRS) signals. In addition, CHEUI also reveals the co - existence of m6A and m5C in single mRNA molecules in cell - line and tissue transcriptomes, providing a new approach for exploring the functions of the epitranscriptome. The key contributions of the paper are: 1. **Multi - modification detection**: It can detect multiple RNA modification types simultaneously in a single sample, breaking through the limitation that existing methods can usually only detect a single modification type. 2. **High precision**: Through multiple tests using synthetic RNA standards and cell - line data, the high accuracy of CHEUI in single - molecule, transcriptional - site and stoichiometric - ratio aspects has been verified. 3. **Co - existence phenomenon**: The co - existence of m6A and m5C in single mRNA molecules has been discovered, which is of great significance for understanding how RNA modifications work together to regulate gene expression. 4. **Wide applicability**: It is applicable to different biological samples, including cell - line and tissue samples, providing a powerful tool for studying the roles of RNA modifications in physiological and pathological processes. In conclusion, through the development of CHEUI, this paper has solved the key challenges in RNA modification research, that is, how to accurately identify and quantify multiple RNA modifications at the single - molecule level, thus laying the foundation for in - depth understanding of the functions of RNA modifications and their roles in diseases.